Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism IGF-1R agonists(Insulin-like growth factor I receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Insulin-Like Growth Factor I Deficiency | Phase 1 | IL | 16 Oct 2021 |